Use of NeuroSAFE to guide nerve-sparing surgery results in improvement in erectile function at 12 months and urinary continence at 3 months.

King Charles sent shockwaves around the nation in February 2024 when Buckingham Palace announced that he had been diagnosed ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.